CTLA4 and Pruritus: Pruritus with anti–CTLA-4 therapy has been described to be directly associated to the inhibition of the receptor and the enhancement and activation of the immune system in the skin (Fischer, Rosen, Ensslin, Wu, & Lacouture, 2013).